Diagnostic accuracy of atypical P-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis

European Journal of Medical Research

Volumn 9, Issue 9, 2004, Pages 439-448

  Terjung, Birgit ^a   Bogsch, F ^a   Klein, R ^b   Sohne J ^a   Reichel, C ^a   Wasmuth, J C ^a   Beuers, U ^c   Sauerbruch, T ^a   Spengler, U ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

AIH; ANCA; Antineutrophil cytoplasmic antibodies; PSC

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD; CASE CONTROL STUDY; CHILD; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; ROC CURVE; SCLEROSING CHOLANGITIS; SENSITIVITY AND SPECIFICITY; SMOOTH MUSCLE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHOLANGITIS, SCLEROSING; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS, AUTOIMMUNE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE, SMOOTH; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 16644390618     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Johnson PJ, McFarlane IG. Meeting report: international autoimmune hepatitis group. Hepatology 1993; 18: 998-1005.
2. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Champan RW, Cooksley WG et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
3. Miyakawa H, Kitzawa, E, Abe K, Kawaguchi N, Fuzikawa H, Kikuchi K, Kako M, Komatsu T, Hayashi N, Kiyosawa, K. Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis. J Gastroenterol 1997; 32: 769-776.
4. Bianchi FB, Cassani F, Lenzi M, Ballardini G, Muratori L, Giostra F, Zauli D. Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience. Dig Dis Sci 1996; 41: 166-171.
5. Czaja A, Carpenter HA. Validation of a scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci 1996; 41: 305-314.
6. Dickson RC, Gaffey MJ, Ishitani MB, Roarty TP, Driscoll CJU, Caldwell SH. The international autoimmune hepatitis score in chronic hepatitis C. J Viral Hepatol 1997; 4: 121-128.
7. Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M, Tsuji T, Omata M. Present status of autoimmune hepatitis in Japan: correlating the characteristics with international criteria in an area with high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hepatol 1997; 26: 1207-1212.
8. Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, Schrumpf E. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 1996; 23: 1369-1376.
9. Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, Darnis F, Levy VG, Grippon P, et al. Chronic active hepatitis associated with anti-liver/kidney microsome antibody type 1: a second type of autoimmune hepatitis. Hepatology 1987; 7: 1333-1339.
10. Stechemesser E, Mein R, Berg PA. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology 1993; 18: 1-9.
11. Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum Buesschenfelde KH, Lohse AW. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Lancet 2000; 355: 1510-1515.
12. Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Buschenfelde KH. Characterization of a new sub-group of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987; i: 292-294.
13. Czaja AJ, Manns M. The validity and importance of sub-types in autoimmune hepatitis: a point of view. Am J Gastroenterol 1995; 90: 1206-1211.
14. McFarlane IG. The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. Gut 1998; 42: 599-602.
15. Maddrey WC. How many types of autoimmune hepatitis are there? Gastroenterology 1993; 105: 1571-1574.
16. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
17. Treichel U, McFarlane BM, Seki T, Krawitt EL, Alessi N, Stickel F, McFarlane IG, Kiyosawa K, Furuta S, Freni MA, et al. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology 1994; 107: 799-804.
18. Abuaf N, Johanet C, Chretien P, Martini E, Soulier E, Laperche S, Homberg JC. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology 1992; 16: 892-898.
19. Toda G, Ikeda Y, Kashiwagi M, Iwamori M, Oka H. Hepatocyte plasma membrane glycosphingolipid reactive with sera from patients with autoimmune chronic active hepatitis: its identification as sulfatide. Hepatology 1990; 12: 664-670.
20. Mulder AHL, Horst G, Haagsma EB, Kleibeuker JH, Kallenberg CGM. Antineutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993; 17: 411-417.
21. Hardarson S, LaBrecque DR, Mitros FA, Neil GA, Goeken JA. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. Am J Clin Pathol 1993; 99: 277-281.
22. Targan S, Landers C, Vidrich A, Czaja AL. High-titer antineutrophil cytoplasmic antibodies in type 1 autoimmune hepatitis. Gastroenterology 1995; 108: 1159-1166.
23. Bansi DS, Fleming KA, Chapman RW. Antineutrophil cytoplasmic antibodies in autoimmune hepatitis. Gastroenterology 1995; 109: 2049-2055.
24. Zauli D, Ghetti S, Grassi A, Descovich C, Cassani F, Ballardini G, Muratori L, Bianchi FB. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology 1997; 25: 1105-1107.
25. Roozendaal C, de Jong MA, van den Berg AP, van Wijk RT, Limburg PC, Kalllenberg CG. Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases. J Hepatol 2000 32: 734-41.
26. Bruns DE, Huth EJ, Magid E, Young DS. Toward a checklist for reporting of studies of diagnostic accuracy of medical tests. Clin Chem 2000; 46: 893-895.
27. Wiesner RH. Diagnostic criteria, clinical manifestations and natural history of primary sclerosing cholangitis. In: Krawitt EL, Wiesner RH, Nisioka M, eds. Autoimmune Liver Diseases. 2nd ed. Amsterdam: Elsevier Science Publisher B.V. 1998: 381-412.
28. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335: 1570-1580.
29. McCullough AJ, O'Connor JF. Alcoholic liver disease: Proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 2022-2036.
30. Hoofnagle JH. Hepatitis C: The clinical spectrum of disease. Hepatology 1997; 26:15S.
31. Woodward J, Neuberger J. Autoimmune overlap syndromes. Hepatology 2001; 3-3: 994-1002.
32. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989; 97 (suppl.6):12-13.
33. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv lmmunol 1989; 44: 93-151.
34. Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hageh EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999; 111: 507-513.
35. Terjung B, Worman HJ, Herzog V, Sauerbruch T, Spengler U. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy. Clin Exp Immunol 2001; 126: 37-46.
36. Czaja AJ, Nishioka M, Morshed SA, Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 1994; 107: 200-207.
37. Toh BH. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol 1979; 38: 621-628.
38. Berg PA, Sayers T, Wiedmann KH, Kloppel G, Lindner H. Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies. Lancet 1980; 2: 1329-1332.
39. Gershwin ME, Coppel R, Mackay IR. Primary biliary cirrhosis and mitochondrial autoantigen-insights from molecular biology. Hepatology 1988; 8:147-151.
40. Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cystochrome P450db1. J Clin Invest 1989; 83: 1066-1072.
41. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 1983; 148: 839-843.
42. Zweig MH, Campell G. Receiver-operating characteristics (ROC), plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-577.
43. Bland JM, Altman DG. Statistics notes: the odds ratio. BMJ 2000; 320: 1468.
44. Orth T, Gerken G, Kellner R, Meyer zum Buesschenfelde KH, Mayet WJ. Actin is the target antigen of antineu trophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1. J Hepatol 1997; 26: 37-47.
45. Sobajima J, Ozaki S, Uesugi H, Osakada F, Inoue M, Fukuda Y, Shirakawa H, Yoshida M, Rokuhara A, Imai H, Kiyosawa K, Nakao K. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut 1999; 44: 867-873.
46. Angulo P, Peter JB, Gershwin E, DeSotel CK, Shoenfeld Y, Ahmed AEE, Lindor KD. Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol 2000; 32: 182-187
47. Duerr RH, Targan SR, Landers CJ, Larusso NF, Lindsay KL, Wiesner RH, Shanahan F. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100: 1385-1391.
48. Roozendaal C, Van Milligen de Wit AW, Haagsma EB, Horst G, Schwarze C, Peter HH, Kleibeuker JH, Tervaert JW, Limburg PC, Kallenberg CG. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features. Am J Med 1998; 105: 393-399.
49. Orth T, Gerken G, Meyer zum Bueschenfelde KH, Mayet WJ. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity. Z Gastroenterol 1997; 35: 113-121.
50. Vogel A, Wedemeyer H, Manns MP, Strassburg CP. Autoimmune hepatitis and overlap syndromes. J Gastroenterol Hepatol 2002; 17: S389-S398.
51. Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 1998; 28: 360-365.
52. Berg PA, Klein P, Autoimmune hepatitis and overlap syndrome: diagnosis. Schweiz Rundsch Med Prax 2002; 91: 1339-1346.
53. Terjung B, Herzog V, Worman HJ, Gestmann I, Bauer C, Sauerbruch T, Spengler U. Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel disease and hepatobiliary disorders co-localize with nuclear lamina proteins. Hepatology 1998; 28: 332-340.
54. Terjung B, Spengler U, Sauerbruch T, Worman HJ. Atypical p-ANCA in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 2000; 119: 310-322.